Intriguingly, SIRT1 inhibitor countervailed the inhibitory effect of AG on NLRP3 inflammasome, which indicated that targeting the SIRT1-mediated NLRP3 inflammasome axis might be a possible mechanism of AG to treat depression (Tong et al., 2020). This evidence concerns the gene NLRP3 and depressive symptom measurement.